IngenioRx quarterly Drug and Biologic Pipeline Update available

The Q4 2020 IngenioRx Drug and Biologic Pipeline Update provides more insight into emerging biopharma therapies. The update provides our insight and analysis to help you understand how the drug and biologic pipeline could change in 2021. Highlights include:

An examination of a novel therapy that may slow clinical decline in patients with Alzheimer’s disease
In-depth reviews of proposed treatments for uterine fibroids and a rare metabolic disease in children
An analysis of how and why specialty drugs are prominent in the pipeline
Market trends likely affecting the pipeline and the state of gene therapies

View and download the quarterly update to learn more.

We’re promoting our value to groups still with Humana

We will continue our Large and Small Group marketing campaign for employers still with Humana. It will continue through April and, tentatively, through September. If one of your clients responds, we will connect with you to keep you involved. Our messaging will showcase Anthem’s value story and ...

Time Well Spent: Understanding Autism spectrum disorder

Time Well Spent Wellness Calendar resources for April focus on Autism spectrum disorder. Autism spectrum disorder (ASD) is a condition that causes people to behave, communicate, interact, and learn in ways that are different from most people. ASD impacts all racial, ethnic, and socioeconomic gro...

IngenioRx quarterly Drug and Biologic Pipeline Update available

More Articles

We’re promoting our value to groups still with Humana

Time Well Spent: Understanding Autism spectrum disorder